Yi Peng

Yi Peng is currently the Director of RWE Analytics at AbbVie, where they lead efforts in utilizing real-world evidence to inform research and clinical decision-making. With over 15 years of experience in epidemiology, health economics, and policy research, Yi has worked extensively with cross-functional teams in various therapeutic areas. Prior to their current role, they held positions at companies including Prime Therapeutics and Hennepin Healthcare Research Institute, where they executed studies and collaborated with pharmaceutical clients. Yi has co-authored over 30 peer-reviewed publications and presented more than 100 conference abstracts, demonstrating a strong commitment to advancing knowledge in the field.